F 
6,320
+3.27%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in KRW, from our data supplier.
Revenue
₩18.67bn
FY2016FY2025
Net income
−₩11.25bn
FY2016FY2025
Free cash flow
−₩10.95bn
FY2016FY2025
Shareholders' equity
₩54.65bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₩18.67bn | ₩17.29bn | ₩13.97bn | ₩12.57bn | ₩11.82bn | ₩11.01bn | ₩8.17bn | ₩5.64bn | ₩3.00bn | ₩1.63bn |
| Research and development | ₩3.58bn | ₩4.18bn | ₩2.36bn | ₩7.64bn | ₩4.17bn | ₩1.94bn | ₩877.5m | ₩648.9m | ₩628.8m | ₩384.7m |
| Operating income | −₩7.75bn | −₩9.47bn | −₩8.41bn | −₩13.44bn | −₩7.90bn | −₩4.89bn | −₩5.50bn | −₩12.10bn | −₩4.53bn | −₩3.88bn |
| Net income | −₩11.25bn | −₩9.42bn | −₩6.71bn | −₩13.96bn | −₩3.42bn | −₩23.10bn | −₩5.37bn | −₩11.97bn | −₩4.49bn | −₩27.29bn |
| Diluted earnings per share | -485.40 | -426.19 | -303.61 | -631.73 | -177.01 | -1,697.03 | -933.70 | -1,425.98 | -547.12 | -3,324.44 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | ₩74.53bn | ₩74.42bn | ₩72.83bn | ₩88.72bn | ₩77.14bn | ₩82.46bn | ₩63.21bn | ₩64.05bn | ₩36.00bn | ₩33.11bn |
| Cash and short-term investments | — | ₩33.39bn | ₩25.76bn | ₩40.73bn | ₩32.62bn | ₩46.80bn | ₩28.35bn | ₩38.28bn | ₩11.15bn | ₩23.45bn |
| Total liabilities | ₩19.70bn | ₩20.04bn | ₩8.92bn | ₩18.58bn | ₩24.42bn | ₩39.08bn | ₩52.05bn | ₩47.59bn | ₩8.80bn | ₩1.58bn |
| Debt | — | ₩10.16bn | ₩3.68bn | ₩12.01bn | ₩18.65bn | ₩22.69bn | ₩35.74bn | ₩41.95bn | ₩4.94bn | ₩1.00bn |
| Shareholders' equity | ₩54.65bn | ₩54.38bn | ₩63.77bn | ₩70.14bn | ₩52.72bn | ₩43.37bn | ₩11.16bn | ₩16.46bn | ₩27.20bn | ₩31.53bn |
| Shares outstanding | 23m | 22m | 22m | 22m | 19m | 14m | 6m | 8m | 8m | 8m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −₩2.43bn | −₩3.21bn | −₩3.72bn | −₩7.61bn | −₩2.95bn | −₩2.28bn | −₩2.71bn | −₩3.34bn | −₩2.84bn | −₩2.20bn |
| Capital spending | −₩8.53bn | −₩1.88bn | −₩2.42bn | −₩2.99bn | −₩8.39bn | −₩3.44bn | −₩6.93bn | −₩8.34bn | −₩6.05bn | −₩796.5m |
| Free cash flow | −₩10.95bn | −₩5.09bn | −₩6.14bn | −₩10.60bn | −₩11.34bn | −₩5.71bn | −₩9.64bn | −₩11.68bn | −₩8.89bn | −₩3.00bn |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩4.27bn | ₩6.36bn | ₩6.16bn | ₩3.79bn | ₩3.64bn | ₩5.08bn | ₩6.24bn | ₩4.18bn |
| Operating income | ₩2.41bn | −₩2.21bn | — | −₩2.53bn | ₩2.67bn | −₩1.89bn | −₩484.2m | −₩2.34bn |
| Net income | ₩2.31bn | −₩2.06bn | −₩7.57bn | −₩3.82bn | ₩2.59bn | −₩2.45bn | −₩555.1m | −₩3.53bn |
| Diluted earnings per share | 99.66 | -88.83 | -326.60 | -167.42 | 113.49 | -110.83 | -25.12 | -159.96 |
| Cash from operations | −₩2.84bn | ₩13.0m | −₩1.28bn | −₩1.43bn | ₩303.0m | −₩22.0m | −₩3.21bn | −₩2.34bn |
| Capital spending | −₩797.0m | −₩1.00bn | −₩6.56bn | −₩756.0m | −₩499.0m | −₩709.0m | −₩1.88bn | −₩1.25bn |
| Free cash flow | −₩3.63bn | −₩991.0m | −₩7.84bn | −₩2.18bn | −₩196.0m | −₩731.0m | −₩5.09bn | −₩3.58bn |
| Total assets | ₩68.41bn | ₩69.72bn | ₩74.53bn | ₩70.28bn | ₩71.20bn | ₩73.28bn | ₩74.42bn | ₩77.83bn |
| Cash and short-term investments | — | — | — | — | — | ₩32.77bn | ₩33.39bn | ₩35.23bn |
| Debt | ₩2.11bn | — | — | — | — | ₩1.82bn | ₩1.81bn | ₩12.62bn |
| Shareholders' equity | ₩54.91bn | ₩52.60bn | ₩54.65bn | ₩50.72bn | ₩54.54bn | ₩51.94bn | ₩54.38bn | ₩54.93bn |
Financial ratios
Data as of 1 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Operating margin | -41.5% | -54.7% | -60.2% | -106.9% | -66.9% | -44.4% | — |
| Net margin | -60.3% | -54.5% | -48.0% | -111.0% | -28.9% | -209.8% | — |
| Return on equity | -20.6% | -17.3% | -10.5% | -19.9% | -6.5% | -53.3% | — |
| Return on assets | -15.1% | -12.7% | -9.2% | -15.7% | -4.4% | -28.0% | — |
| Free cash flow yield | — | — | — | — | — | — | 8.9% |
| Revenue growth | 8.0% | 23.8% | 11.1% | 6.4% | 7.3% | 34.9% | — |
| Earnings growth | 19.5% | 40.4% | -51.9% | 308.2% | -85.2% | 330.3% | — |
| Current ratio | 2.37x | 2.50x | 8.79x | 3.29x | 3.63x | 2.45x | — |
| Debt to equity | — | 0.00x | 0.04x | 0.03x | 0.16x | 0.32x | 1.15x |
| Equity ratio | 73.3% | 73.1% | 87.6% | 79.1% | 68.3% | 52.6% | — |
| Interest coverage | -7.44x | -14.57x | -17.59x | -9.90x | -5.98x | -1.31x | — |
| R&D as a share of sales | 19.2% | 24.2% | 16.9% | 60.8% | 35.3% | 17.6% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 14.1% | 11.1% | 29.1% |
| Operating income | -16.8% | 9.6% | 12.3% |
| Net income | -6.9% | -13.4% | -7.5% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | -47.9% | -62.5% | -60.8% | -76.3% |
| Net margin | -57.5% | -66.1% | -79.5% | -134.5% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -53.0 | -33.9 | -29.0 | -12.7 | -60.9 | -8.5 | -6.3 | -3.7 | -15.2 | -2.3 |
| Price to sales | 31.9 | 18.4 | 13.9 | 14.1 | 17.6 | 17.8 | 4.1 | 7.8 | 22.8 | 39.2 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 13-for-10 split · 24 Oct 2022
- 2075-for-1974 split · 2 Sept 2022
- 6-for-5 split · 4 Aug 2020
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.